Evidence map›Paper›PMID 26138448›Full record

ArticleAging cell2015

Regulation of p53 during senescence in normal human keratinocytes.

Reuben H Kim, Mo K Kang, Terresa Kim, Paul Yang, Susan Bae, Drake W Williams, Samantha Phung, Ki-Hyuk Shin, Christine Hong, No-Hee Park

Open access · goldAbstract read
In one paragraph

Article in Aging cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 47 citations in OpenAlex.

  1. Cellular senescence in kidney diseases.Chinese medical journal · 2025
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. IL-36 Induces Bisphosphonate-Related Osteonecrosis of the Jaw-Like Lesions in Mice by Inhibiting TGF-β-Mediated Collagen Expression.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2017
    Article
  15. Article
  16. Modeling the Etiology of p53-mutated Cancer Cells.The Journal of biological chemistry · 2016
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Reuben H KimUCLA School of Dentistry, Los Angeles, CA, 90095, USA.
Mo K KangUCLA School of Dentistry, Los Angeles, CA, 90095, USA.
Terresa KimUCLA School of Dentistry, Los Angeles, CA, 90095, USA.
Paul YangUCLA School of Dentistry, Los Angeles, CA, 90095, USA.
Susan BaeUCLA School of Dentistry, Los Angeles, CA, 90095, USA.
Drake W WilliamsUCLA School of Dentistry, Los Angeles, CA, 90095, USA.
Samantha PhungUCLA School of Dentistry, Los Angeles, CA, 90095, USA.
Ki-Hyuk ShinUCLA School of Dentistry, Los Angeles, CA, 90095, USA.
Christine HongUCLA School of Dentistry, Los Angeles, CA, 90095, USA.
No-Hee ParkUCLA School of Dentistry, Los Angeles, CA, 90095, USA.
University of California, Los Angeles · USUCLA Jonsson Comprehensive Cancer Center

Funding

UCLA Dentist-Scientist and Oral Health-Researcher Training ProgramT90DE022734 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WONG, DAVID T · 2012 to 2017
$2.3M
Epigenetic Control of HPV-associated Oral CarcinogenesisR01DE023874 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KIM, REUBEN HAN-KYU, WANG, CUN-YU · 2013 to 2017
$2.3M
Molecular mechanisms of drug-induced ONJ and osteomucosal chronic woundsR01DE023348 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KIM, REUBEN HAN-KYU · 2013 to 2017
$1.9M
Combined Effect on HIV and HPV in Oral CancerK08DE017121 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KIM, REUBEN HAN-KYU · 2007 to 2011
$571k
NIDCR NIH HHS K08DE17121NIDCR NIH HHS R01DE023348NIDCR NIH HHS R01DE023874NIDCR NIH HHS T90 DE022734
6 · The paper itself

Abstract

p53, the guardian of the genome, is a tumor suppressor protein and critical for the genomic integrity of the cells. Many studies have shown that intracellular level of p53 is enhanced during replicative senescence in normal fibroblasts, and the enhanced level of p53 is viewed as the cause of senescence. Here, we report that, unlike in normal fibroblasts, the level of intracellular p53 reduces during replicative senescence and oncogene-induced senescence (OIS) in normal human keratinocytes (NHKs). We found that the intracellular p53 level was also decreased in age-dependent manner in normal human epithelial tissues. Senescent NHKs exhibited an enhanced level of p16(INK4A) , induced G2 cell cycle arrest, and lowered the p53 expression and transactivation activity. We found that low level of p53 in senescent NHKs was due to reduced transcription of p53. The methylation status at the p53 promoter was not altered during senescence, but senescent NHKs exhibited notably lower level of acetylated histone 3 (H3) at the p53 promoter in comparison with rapidly proliferating cells. Moreover, p53 knockdown in rapidly proliferating NHKs resulted in the disruption of fidelity in repaired DNA. Taken together, our study demonstrates that p53 level is diminished during replicative senescence and OIS and that such diminution is associated with H3 deacetylation at the p53 promoter. The reduced intracellular p53 level in keratinocytes of the elderly could be a contributing factor for more frequent development of epithelial cancer in the elderly because of the loss of genomic integrity of cells.

Indexed as

Cellular SenescenceCell ProliferationCells, CulturedDNA MethylationHistonesHumansKeratinocytesTumor Suppressor Protein p53HistonesTumor Suppressor Protein p53agingcancerepigeneticshuman keratinocytesp53replicative senescence

Identifiers

PMID26138448
PMCPMC4568971
OpenAlexW1716557529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.